Evolution of our understanding of MS-COVID-19 interactions and concerns for vaccination

As the news of approval of COVID-19 vaccination emerge, neurologists across the globe ponder upon whether to use immunotherapies in patients with Multiple Sclerosis (MS). This paper highlights the mechanism of various disease modifying therapies (DMTs) as well as the recently approved Pfizer and Mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Podury, Sanjiti, Khan, Erum, Tandon, Medha, Jaiswal, Shruti, Sriwastava, Shitiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166521/
https://www.ncbi.nlm.nih.gov/pubmed/34275536
http://dx.doi.org/10.1016/j.jocn.2021.05.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166521/
https://www.ncbi.nlm.nih.gov/pubmed/34275536
http://dx.doi.org/10.1016/j.jocn.2021.05.063

Ejemplares similares